{"id":182077,"date":"2021-02-18T22:34:03","date_gmt":"2021-02-18T19:34:03","guid":{"rendered":"https:\/\/en.buradabiliyorum.com\/what-comes-next-uhns-continued-effort-in-defeating-covid-19\/"},"modified":"2021-02-18T22:34:03","modified_gmt":"2021-02-18T19:34:03","slug":"what-comes-next-uhns-continued-effort-in-defeating-covid-19","status":"publish","type":"post","link":"https:\/\/buradabiliyorum.com\/en\/what-comes-next-uhns-continued-effort-in-defeating-covid-19\/","title":{"rendered":"#What comes next: UHN\u2019s continued effort in defeating COVID-19"},"content":{"rendered":"

“#What comes next: UHN\u2019s continued effort in defeating COVID-19<\/strong>”<\/p>\n

\n Post-vaccine, there are still a lot of unknowns when it comes to the virus\u2019 long-term impacts\n <\/div>\n
\n

Dr. Bradly Wouters was present as one of Canada\u2019s first COVID-19 vaccines was administered to a personal support worker at Toronto\u2019s University Health Network (UHN)<\/a> in December. A symbol of optimism, that historic day has affirmed the value of science<\/a> and global cooperation amidst the pandemic. \u201cI don\u2019t think we can understate how incredible it is that the world collectively developed safe, effective vaccines in a period of 10 months,\u201d says Dr. Wouters, UHN\u2019s Executive Vice President of Science and Research. After months of collective distress, Canadians are beginning to anticipate an end to what many have described as the greatest challenge of our lifetime.<\/p>\n

As the vaccine rollout continues, however, it\u2019s crucial that Canadians are kept informed about the ongoing challenges ahead. For Dr. Wouters and his colleagues at UHN, this requires continued research to address the unknowns of this virus and develop solutions. With more than 187 app<\/a>roved COVID-19 research projects currently underway at UHN, its world-renowned research team offers a unique opportunity for leadership in Canadian health care to make a global impact.<\/p>\n

From transmissibility to treatment and the long-term effectiveness of vaccines, there\u2019s now an emphasis to study the many stages of COVID-19 and its different components. \u201cIt\u2019s about understanding how this virus interacts with the body,\u201d says Dr. Wouters, adding that these studies are \u201cvital to our ability to deal with the consequences of infection.\u201d Specifically, this encompasses the consequences during infection and post-infection. There are still a lot of unknowns when it comes to the long-term impacts of COVID-19. Reports range from excessive lung inflammation to blood clot-induced strokes and neurological damage. For Dr. Wouters, \u201cunderstanding that biology is dire.\u201d<\/p>\n

Encompassing Toronto General<\/a> and Toronto Western hospitals, Princess Margaret Cancer Centre, Toronto Rehabilitation Institute, and The Michener Institute of Education, UHN is home to a diverse collection of research infrastructure suited to address these complex challenges. A clinical trial out of the Peter Munk Cardiac Centre, for example, has discovered the common blood thinner, heparin, may prevent the need for intubation and mechanical ventilation in hospitalized COVID-19 patients. Additionally, UHN is home to the Toronto Centre for Liver Disease, which, in a study released just this month, showed that an antiviral medication known to control hepatitis virus infections can significantly speed up recovery for mild to moderate COVID-19, preventing people from getting sicker and reducing the spread of the virus to others.<\/p>\n

Largely credited for sustaining such research initiatives are UHN\u2019s philanthropic supporters. \u201cPhilanthropy is a core component to research at UHN\u201d says Dr. Wouters. \u201cIt\u2019s been especially important in our initial response to the pandemic\u2014within weeks of the pandemic being announced, so many of these projects were jump-started by donor support.\u201d<\/p>\n

Decades of research in infectious disease, immunology and vaccines played a fundamental role in the swift development of the COVID-19 vaccines. \u201cThe global scientific community had done the science to make this possible before the pandemic even started,\u201d says Dr. Wouters. Knowledge of the coronavirus\u2019 structural biology provided a launchpad for companies to move quickly\u2014a testament to the necessity of scientific research and funding for that research.<\/p>\n

What comes next will require the same global commitment and logistics practiced in vaccine development. Largely donor driven, UHN\u2019s clinical research initiatives across a wide range of disciplines will continue to study and develop solutions that protect healthcare workers, prevent community spread and find advanced treatment for those infected with COVID-19. This is ultimately the next step toward ending the pandemic and for Dr. Wouters, \u201ca major lesson in better preparing ourselves for any pandemic in the future.\u201d<\/p>\n

Click here<\/a> to donate to UHN\u2019s COVID-19 fund today to help support critical research projects and the health and well-being of staff and patients.<\/em>
\n<\/span><\/p><\/div>\n

If you liked the article, do not forget to share it with your friends. Follow us on\u00a0Google News<\/a><\/span>\u00a0too, click on the star and choose us from your favorites.<\/span><\/strong><\/p><\/blockquote>\n

\n

For forums sites go to Forum.BuradaBiliyorum.Com<\/a><\/span><\/strong><\/p>\n<\/blockquote>\n

\n

If you want to read more News<\/a> articles, you can visit our General category.<\/a><\/span><\/strong><\/p>\n<\/blockquote>\n

Source<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

“#What comes next: UHN\u2019s continued effort in defeating COVID-19” Post-vaccine, there are still a lot of unknowns when it comes to the virus\u2019 long-term impacts Dr. Bradly Wouters was present as one of Canada\u2019s first COVID-19 vaccines was administered to a personal support worker at Toronto\u2019s University Health Network (UHN) in December. A symbol of…<\/p>\n","protected":false},"author":1,"featured_media":182078,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/www.macleans.ca\/wp-content\/uploads\/2021\/02\/Brad_Wouters_21Feb2019_StRIDe-3-750x422.jpg","fifu_image_alt":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-182077","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general"],"_links":{"self":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/182077","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/comments?post=182077"}],"version-history":[{"count":0,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/182077\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media\/182078"}],"wp:attachment":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media?parent=182077"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/categories?post=182077"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/tags?post=182077"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}